Institution statistics

BAYER AG - Germany 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:> 1000
Total Number of Projects:200-300
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):800-900
2012
Criterium:Position:
Overall Score:700-800
Total Project Funding per Partner:800-900
Total Number of Projects:66
Total Project Funding:600-700
Networking Rank (Reputation):300-400
Networking Rank (Reputation):300-400
Partner Constancy:46
Project Leadership Index:75
Diversity Index:41
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:600-700
Project Leadership Index:700-800
Diversity Index:700-800
2010
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:300-400
Total Number of Projects:400-500
Total Project Funding:200-300
Networking Rank (Reputation):300-400
Partner Constancy:500-600
Project Leadership Index:600-700
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:300-400
Total Number of Projects:300-400
Total Project Funding:200-300
Networking Rank (Reputation):300-400
Partner Constancy:200-300
Project Leadership Index:300-400
Diversity Index:400-500
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:700-800
Project Leadership Index:700-800
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:500-600
Project Leadership Index:500-600
Diversity Index:> 1000
Ranking timeline:

European project participation (2010-01-01 - 2021-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 98
As coordinator: 1
As participant: 96
Sole participant: 1
Coordinator / Participant Ratio: 0.01*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 21.202.485 1.011.154 5
2020 0 56.771.318 0 5
2019 0 119.550.151 104.388 13
2018 0 158.450.518 0 15
2017 0 110.809.331 0 8
2016 172.800 25.019.666 0 1 3
2015 5.997.550 24.228.670 1.175.350 1 7
2014 0 7.794.899 400.000 2
2013 0 42.834.903 715.041 9
2012 0 32.826.256 603.207 7
2011 0 41.526.048 309.422 10
2010 0 75.369.716 3.898.684 12
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V13
JANSSEN PHARMACEUTICA NV11
NOVARTIS PHARMA11
ASTRAZENECA10
PFIZER LIMITED10
KATHOLIEKE UNIVERSITEIT LEUVEN9
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG7
ELI LILLY AND COMPANY LIMITED7
F HOFFMANNLA ROCHE7
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE7
VTT TECHNICAL RESEARCH CENTRE OF FINLAND7
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT6
SANOFIAVENTIS6
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD6
CHARITE UNIVERSITAETSMEDIZIN BERLIN5
KAROLINSKA INSTITUTE5
UCB BIOPHARMA5
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN5
ABBVIE INC4
CONSIGLIO NAZIONALE DELLE RICERCHE4
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE4
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN4
TAKEDA DEVELOPMENT CENTRE EUROPE4
UNIVERSITY OF COPENHAGEN4
ASTELLAS PHARMA EUROPE BV3
CELGENE MANAGEMENT SARL3
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL3
DEGUSSA3
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM3
EUROPEAN CANCER PATIENT COALITION3
EUROPEAN MOLECULAR BIOLOGY LABORATORY3
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL3
FORSCHUNGSZENTRUM JULICH3
GOETEBORGS UNIVERSITET3
GRUNENTHAL3
INSTITUT DE RECHERCHES SERVIER3
KING'S COLLEGE LONDON3
NEDERLANDSE ORGANISATIE VOOR TOEGEPAST NATUURWETENSCHAPPELIJK ONDERZOEK TNO3
NOVO NORDISK3
OSPEDALE PEDIATRICO BAMBINO GESU3
SIB INSTITUT SUISSE DE BIOINFORMATIQUE3
STICHTING LYGATURE3
STICHTING VUMC3
TECHNISCHE UNIVERSITEIT EINDHOVEN3
TEVA PHARMACEUTICAL INDUSTRIES LIMITED3
TTOPSTART BV3
UNIVERSIDAD DE NAVARRA3
UNIVERSITA VITASALUTE SAN RAFFAELE3
UNIVERSITE DU LUXEMBOURG3
UNIVERSITEIT UTRECHT3
UNIVERSITY COLLEGE CORK NATIONAL UNIVERSITY OF IRELAND CORK3
UNIVERSITY COLLEGE LONDON3
UNIVERSITY OF BOLOGNA3
UNIVERSITY OF DUNDEE3
UNIVERSITY OF LEEDS3
UNIVERSITY OF NEWCASTLE UPON TYNE3
UNIVERSITY OF TAMPERE3
WEIZMANN INSTITUTE OF SCIENCE3
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS2
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS2
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
ASTRAZENECA UK LIMITED2
BASF SE2
BAYER SCHWEIZ2
CENTRE DE RECHERCHE PUBLIC DE LA SANTE2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
CHRISTIAN DE DUVE INSTITUTE OF CELLULAR PATHOLOGY2
CLINIQUES UNIVERSITAIRES SAINTLUC2
COATEMA COATING MACHINERY2
COMMISSARIAT A L'ENERGIE ATOMIQUE2
DANMARKS TEKNISKE UNIVERSITET2
DEUTSCHES KREBSFORSCHUNGSZENTRUM2
EBERHARD KARLS UNIVERSITAET TUEBINGEN2
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE2
ERASMUS UNIVERSITEIT ROTTERDAM2
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS2
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE2
EUROPEAN HEMATOLOGY ASSOCIATION2
EUROPEAN PATIENTS' FORUM2
FACHHOCHSCHULE NORDWESTSCHWEIZ2
FORUM DES PATIENTS EUROPEENS2
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS2
FRIEDRICHALEXANDERUNIVERSITAET ERLANGEN NUERNBERG2
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT2
INSTITUT CURIE2
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS2
INSTITUT FUER MIKROTECHNIK MAINZ2
INVITE2
LEIDS UNIVERSITAIR MEDISCH CENTRUM2
MERCK SHARP & DOHME CORP2
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS2
OWKIN FRANCE2
REGION HOVEDSTADEN2
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU2
STATENS LEGEMIDDELVERK2
STICHTING KATHOLIEKE UNIVERSITEIT2
SYDDANSK UNIVERSITET2
TAKEDA PHARMACEUTICALS INTERNATIONAL2
TECHNISCHE UNIVERSITAET MUENCHEN2
TECHNISCHE UNIVERSITAT DORTMUND2
Constancy:

Total number of partners:854

Partner loyalty:
Frequent Partner: (> 2 projects): 263
Rare Partner: 591

Frequent / Rare Partner Ratio: 0.45

Diversity:

Categories:
Category:No:
INDUSTRY AND TECHNOLOGY9
RTD HORIZONTAL TOPICS6
BIOLOGICAL SCIENCES4
SOCIAL AND ECONOMIC CONCERNS3
ENERGY2

Project overview:

Start dateProjectacronymrolefundingpartners
2021-01-01Drug Absorption in Geriatric Patients and Older People: a training network innovating drug development for the advanced age population AGePOPparticipant2.790.4436
2021-01-01A fully integrated, animal-free, end-to-end modelling approach to oral drug product development InPharmaparticipant3.475.40211
2021-01-01Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials SISAQOL-IMIparticipant2.281.84033
2021-01-01Advanced machine learning for Innovative Drug Discovery AIDDparticipant3.926.61515
2021-01-01Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy T2EVOLVEparticipant8.728.18527
2020-11-01Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment Gravitate-Healthparticipant9.280.00040
2020-10-01HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS HARMONY PLUSparticipant6.715.62539
2020-09-01Prioritisation and Risk Evaluation of Medicines in the EnviRonment PREMIERparticipant4.550.00025
2020-05-01EUbOPEN: Enabling and Unlocking biology in the OPEN EUbOPENparticipant27.935.00022
2020-01-01PharmaLedger PharmaLedgerparticipant8.290.69429
2019-10-01Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies Immune-Imageparticipant15.000.00022
2019-09-01Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials Trials@Homeparticipant19.036.99831
2019-09-01Collaboration for innovation: Establishment of a pan-nematode drug development platform HELPparticipant8.713.3958
2019-07-01Health.E Lighthouse Support Initiative HELoSparticipant499.4798
2019-06-01MachinE Learning Ledger Orchestration for Drug DiscoverY MELLODDYparticipant8.000.00017
2019-04-01Thrombo-inflammation in cardiovascular disease TICARDIOparticipant3.944.03810
2019-04-01Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement MOBILISE-Dparticipant25.395.89734
2019-03-01CARdiomyopathy in type 2 DIAbetes mellitus CARDIATEAMparticipant6.700.00021
2019-03-01EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells EBiSC2participant4.599.64816
2019-03-01A multidisciplinary approach towards sustainable improvement in rare diseases care uniting Europe's top class vascular research to find new treatment strategies for vascular anomalies V.A. Cureparticipant3.792.13617
2019-03-01Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts IMMUcanparticipant17.830.00028
2019-01-01FAIRplus FAIRplusparticipant3.996.15022
2019-01-01A European standardization framework for data integration and data-driven in silico models for personalized medicine EU-STANDS4PMparticipant2.042.41116
2018-12-01European Screening Centre; Unique Library for Attractive Biology ESCulabparticipant18.249.99320
2018-11-01European Health Data and Evidence Network EHDENparticipant14.105.75022
2018-09-01Ensuring the future of EUPATI beyond 2020 EFOEUPATIparticipant365.24312
2018-09-01Quantitative T cell Immunology and Immunotherapy QuanTIIparticipant3.923.65310
2018-07-01Research empowerment on solute carriers (ReSOLUTE) ReSOLUTEparticipant12.000.00014
2018-06-01The GetReal Initiative GetReal Initiativeparticipant1.750.00017
2018-05-01RustWatch: A European early-warning system for wheat rust diseases RUSTWATCHparticipant4.999.99925
2018-05-01Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope PIONEERparticipant6.000.00035
2018-05-01Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production iConsensusparticipant4.700.00019
2018-05-01conect4children (COllaborative Network for European Clinical Trials For Children) c4cparticipant67.000.00048
2018-04-01Improving the care of patients suffering from acute or chronic pain IMI-PainCareparticipant11.225.27140
2018-03-01Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. PARADIGMparticipant4.498.93134
2018-01-01Super-resolution optical microscopy of nanosized pore dynamics in endothelial cells DeLIVERparticipant3.728.51314
2018-01-01Meiotic Control of Recombination in Crops MEICOMparticipant3.107.82019
2018-01-01Combatting the CardioRenal Syndrome: towards an integrative Analysis to reduce cardiovascular burden in chronic kidney disease CaReSyAnparticipant2.795.34616
2017-09-01Develop and validate appropriate and acceptable outcome measures in intermediate age-related macular degeneration for future interventional clinical trials - Sofia ref.: 116076 MACUSTARparticipant8.025.00013
2017-09-01Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management eTRANSAFEparticipant20.000.00027
2017-03-01Big Data 4 Better Hearts - Sofia ref.: 116074 BigData Heartparticipant9.664.97019
2017-02-01Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 DO-ITparticipant3.549.83336
2017-01-01Internet of Food and Farm 2020 IoF2020participant29.999.52882
2017-01-01Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 HARMONYparticipant20.200.00053
2017-01-01ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064 ITCC-P4participant7.370.00021
2017-01-01Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 IB4SD-TRISTANparticipant12.000.00021
2016-11-01Educational Network in Ocular Drug Delivery and Therapeutics OcuTherparticipant3.933.72918
2016-10-01Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 PREFERparticipant6.000.00033
2016-09-01Highly Efficient and Thermotolerant Wheat HEAT-WHEATcoordinator172.8001
2016-09-01Biomarker Enterprise to Attack DKD - Sofia ref.: 115974 BEAt-DKDparticipant15.085.93731

overview shows latest 50 from 98 projects (2010-01-01 - 2021-12-31)
A full list of projects can be found here:

Alias institution names:
  • BAYER
  • BAYER
  • BAYER AKTIENGESELLSCHAFT
  • BAYER BIOSCIENCE NV
  • BAYER CROPSCIENCE
  • BAYER CROPSCIENCE
  • BAYER CROPSCIENCE BIOLOGICS
  • BAYER CROPSCIENCE NV
  • BAYER MATERIALSCIENCE
  • BAYER PHARMA
  • BAYER SAS
  • BAYER SCHWEIZ
  • BAYER TECHNOLOGY SERVICES

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum